From DCAT Value Chain Insights (VCI)
Recipharm, a contract development and manufacturing organization, has appointed e Shabbir Mostafa to its business management team. as director, business management UK & Ireland, with responsibility for supporting customers in the UK and Ireland and driving sales of Recipharm’s manufacturing services.
He joins Recipharm from Aesica Pharmaceuticals, where he was the business development director with responsibility for global formulation development services and the commercial finished dose business in the UK and Ireland. During his 15- year career, he has also held positions at PCI Pharma Services, Gattefossé, Patheon and IVAX Pharmaceuticals.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription